Focused Wealth Management, Inc Sorrento Therapeutics, Inc. Transaction History

Focused Wealth Management, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$0.74 - $1.83 $5,920 - $14,640	-8,000 Reduced 57.14%	6,000 $0
Q1 2022 Apr 29, 2022	BUY	$2.0 - $4.9 $16,000 - $39,200	8,000 Added 133.33%	14,000 $33,000
Q4 2021 Jan 31, 2022	SELL	$4.65 - $7.23 $25,575 - $39,765	-5,500 Reduced 47.83%	6,000 $28,000
Q3 2021 Oct 12, 2021	BUY	$7.41 - $10.99 $11,115 - $16,485	1,500 Added 15.0%	11,500 $88,000
Q2 2021 Jul 15, 2021	SELL	$6.35 - $10.0 $7,810 - $12,300	-1,230 Reduced 10.95%	10,000 $97,000
Q1 2021 May 03, 2021	SELL	$7.03 - $16.51 $7,030 - $16,510	-1,000 Reduced 8.18%	11,230 $93,000
Q4 2020 Feb 03, 2021	BUY	$5.76 - $11.95 $1,324 - $2,748	230 Added 1.92%	12,230 $83,000
Q2 2020 Jul 24, 2020	BUY	$1.73 - $6.76 $6,920 - $27,040	4,000 Added 50.0%	12,000 $75,000
Q1 2020 May 06, 2020	BUY	$1.57 - $4.76 $10,205 - $30,940	6,500 Added 433.33%	8,000 $15,000
Q4 2019 Jan 21, 2020	BUY	$1.45 - $4.17 $2,175 - $6,255	1,500 New	1,500 $5,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.